primary_duns:
183710748173 Ashley Ave
BSB 358; MSC 509
Charleston, SC 29425
United Stateshttps://research.musc.edu/doing-research/cores/mass-spectrometrycite this facility
Lauren Ball
The MUSC Mass Spectrometry Facility, housed within the Proteomics Center, provides expertise, services, education, and state-of-the-art instrumentation to enhance biomedical research through proteomics and metabolomics. High resolution, accurate mass (HR/AM) mass spectrometers are available for protein identification, characterization of post-translational modifications, protein profiling, identification of protein interactions and drug targets, and biomarker discovery. The core also assists in the development of customized isolation, detection, and characterization of post-translationally modified peptides.
Targeted metabolomics and lipidomics profiling is available using Biocrates MxP Quant 500/500XL, MxP Quant 1000, or AbsoluteIDQ p180 platforms.
Equipment and Computing Infrastructure: Quantitative proteomic experiments (LFQ, nDIA, TMT, SILAC, IS-PRM) can be performed on the Thermo Scientific Vanquish Neo UHPLC Orbitrap Astral Zoom LC-MS/MS with Biopharma and Faims; Easy 1200 nanoLC-Orbitrap Exploris 480 LC-MS/MS; or Easy 1200 nanoLC Orbitrap Fusion Lumos LC-MS/MS with CID, HCD, ETD, EThcD, and UVPD (213 nm) fragmentation capabilities. For sample preparation a Kingfisher Apex, Opentrons OT-2, and Thermo Scientific Vanquish UPLC with diode array detector are available. Software platforms available include MaxQuant, Spectronaut 20, Proteome Discoverer 3.3 with Chimerys, Biopharma Finder, Fragpipe, and Skyline. For database searches a 6 x Intel Xeon Gold 6238R processor (28 cores 56 threads 2.2 GHz up to 4 GHz) with 48GB RAM or a 2 x Intel Xeon E5-2695 processor (18 cores 36 threads 2.1 GHz up to 3.3 GHz) with 128GB RAM are available. For Orbitrap Astral data, the Ardia Platform Server: Dell PowerEdge T550: 2 x Intel Xeon Platinum 8352M processor (64 cores 128 threads 2.3 GHz with 512GB RAM) and Precision 7960 Tower XCTO Base: Intel Xeon w9-3495X (105MB Cache, 56 cores, 112 threads, 1.9GHz to 4.8GHz) are available. Statistical and bioinformatic analyses are performed with Perseus (Max Planck Institute), Graphpad Prism, as well as R-packages from Bioconductor. Raw data are temporarily stored on high-speed servers with automated backup and deposited upon request in the PRIDE repository via the ProteomeXchange consortium. Targeted, absolute quantification of metabolites using the Biocrates platform is available on the Thermo Scientific Vanquish Flex UPLC-TSQ Altis Plus MS and Vanquish Horizon HPLC-Exploris 480 MS. Software used for metabolomic analysis include WebIDQ, Compound Discoverer, Skyline, and MetaboAnalyst.
is_active:
Yesbudget_end:
07/31/2026date_added:
09/13/2025agency_code:
NIHfiscal_year:
2025project_num:
5P30GM140964-05award_amount:
$271,800.00budget_start:
08/01/2025org_name:
MEDICAL UNIVERSITY OF SOUTH CAROLINAorg_state:
SCorg_country:
UNITED STATESorg_zipcode:
294074636primary_duns:
183710748abstract_text:
Proteomics Core – Project Summary The broad objective of the Proteomics Core in the SC COBRE in Oxidants, Redox Balance, and Stress Signaling (Redox COBRE) is to provide state-of-the-art, mass spectrometry (MS)-based proteomic capabilities to enable elucidation of redox signaling mechanisms underlying disease, therapeutic efficacy of cells and drugs, and therapeutic resistance. The Core provides expertise, technical assistance, instrumentation, and interpretation of analytical results for quantitative proteomic experiments and the characterization of redox-sensitive post- translational modifications. During Phase I and II, acquisition of the Orbitrap Elite ETD MS and Orbitrap Fusion Lumos ETD/UVPD MS nano-LC-MS/MS systems (NIH S10 OD010731 and S10 OD025126, PI: Lauren Ball) permitted detection of challenging modifications using complementary peptide fragmentation approaches (ETD and EThcD) and the development of advanced, quantitative proteomic workflows as needed by COBRE investigators. During Phase III, the Core will further develop and update these capabilities to reflect rapid advances in instrumentation, software, and methodologies relevant to redox proteomics. Additionally, in response to the needs of COBRE-affiliated investigators, proteomic tissue imaging capabilities using MALDI- Imaging MS (IMS) will be provided to discern the spatial distribution of enzymatically-digested peptides within tissue biospecimens on slides for the discovery of putative biomarkers and mechanisms underlying disease progression. Detection of disease-specific proteins and redox-sensitive post-translational modifications by LC- MS/MS and IMS has raised the need for targeted proteomic capabilities to verify these findings and further advance translational studies. Providing this complement of proteomic technologies will build on the successes of the Core and position the Core to establish a comprehensive, independent resource. The Core has leveraged previous investments made by the NIGMS during Phase I and II of the COBRE program, the OD and NIGMS for Shared Instrumentation Grants, the NCI Cancer Center Support Grant, and long-standing, strong institutional commitment to develop into a successful institutional resource critical to the needs of Redox COBRE investigators. At present there are 19 COBRE-affiliated users of the Proteomics Core that are PIs of 15 active NIH awards that rely on the LC-MS/MS capabilities, five of these awards also depend on IMS capabilities.project_title:
Proteomics Corecontact_pi_name:
BALL, LAUREN ELIZABETHtotal_cost:
$271,800.00is_active:
Nobudget_end:
03/31/2026date_added:
09/13/2025agency_code:
NIHfiscal_year:
2025project_num:
2P30DK123704-06award_amount:
$151,198.00budget_start:
04/01/2025org_name:
MEDICAL UNIVERSITY OF SOUTH CAROLINAorg_state:
SCorg_country:
UNITED STATESorg_zipcode:
294074636primary_duns:
183710748abstract_text:
Proteomics Core – Abstract The DDRCC Proteomics Core will provide DDRCC Members with cutting edge mass spectrometry resources to support the Center’s thematic areas. During the previous funding period, the Core delivered outstanding services, with extremely high user satisfaction and supported a multitude of manuscripts and grant applications. The DDRCC Proteomics Core is housed within the larger MUSC Proteomics Center and is equipped with state- of-the-art instrumentation and overseen by experts in LC-MS/MS-based proteomics and MALDI mass spectrometry imaging (MSI). The Core provides LC-MS/MS based proteomic methods to interrogate the impact of disease, drugs, and nutrient status on protein abundance, protein interactions and post-translational modifications. DDRCC Members are assisted with customized, project- and modification-specific method development. The Core is one of a handful of facilities throughout the world that provides novel MSI capabilities to spatially resolve metabolites, lipids, glycolipids, glycans, proteins and extracellular matrix proteins in normal and diseased tissues. These capabilities have recently expanded to enable screening for analytes of interest present on captured proteins and cells. DDRCC Members have access to new technologies as they are developed. Drs. Drake, Ball, and Angel lead the Core’s efforts in glycan imaging, LC-MS/MS-based proteomics, and single cell and extracellular imaging, respectively. The aims of the Core are as follows: Aim 1) To provide highly sensitive and reproducible LC-MS/MS-based proteomic methodology; 2) To provide and to continue to develop individualized multiplexed spatial approaches to measure proteins, lipids, and post translational modifications within a single tissue section; 3) To provide and to continue to develop an individualized multimodal single cell spatial omics resource focused on single cell imaging combined with spatial glycomics and spatial matrisomics. Based on polling of the DDRCC Members, we expect this core to continue to be highly utilized.project_title:
Proteomics Corecontact_pi_name:
DRAKE, RICHARD R.total_cost:
$151,198.00is_active:
Yesbudget_end:
07/31/2026date_added:
08/02/2025agency_code:
NIHfiscal_year:
2025project_num:
1S10OD038396-01award_amount:
$1,658,828.00budget_start:
08/01/2025org_name:
MEDICAL UNIVERSITY OF SOUTH CAROLINAorg_state:
SCorg_country:
UNITED STATESorg_zipcode:
294074636primary_duns:
183710748abstract_text:
PROJECT SUMMARY This proposal is requesting funds to acquire a Thermo Scientific Orbitrap Astral Mass Spectrometer for the Mass Spectrometry Facility & Proteomics Center at the Medical University of South Carolina in Charleston, South Carolina. This instrument will support NIH-funded research in areas of cancer, immunotherapy, cardiovascular disease, liver and digestive disease, neurological disease, and addiction. Acquisition of this equipment will provide state-of-the-art research capabilities for our investigators and meet the growing demand for ultra- sensitive quantitative proteomic experiments for limited sample amounts and post-translational modifications of low abundance. This high resolution and accurate mass instrument with Quadrupole, Orbitrap, and Astral mass analyzers exhibits 4-5x faster data acquisition rates than our current instruments improving the sensitivity, quantitative resolution, and reproducibility of measurements. This new advance in technology will speed the discovery of mechanisms underlying disease onset and progression and yield insights into the response to therapeutics. The requested instrumentation is to be housed in the Mass Spectrometry Facility, a University Shared Research Resource Facility, to provide LC-MS/MS based proteomic capabilities to investigators at the Medical University of South Carolina and academic institutions in South Carolina.project_title:
Thermo Scientific Orbitrap Astral Mass Spectrometercontact_pi_name:
BALL, LAUREN ELIZABETHtotal_cost:
$1,658,828.00is_active:
Nobudget_end:
08/31/2022date_added:
09/04/2021agency_code:
NIHfiscal_year:
2021project_num:
1S10OD028692-01A1award_amount:
$772,652.00budget_start:
09/01/2021org_name:
MEDICAL UNIVERSITY OF SOUTH CAROLINAorg_state:
SCorg_country:
UNITED STATESorg_zipcode:
294074636primary_duns:
183710748abstract_text:
PROJECT SUMMARY This proposal is requesting funds to acquire a Quadrupole Orbitrap Hybrid Exploris 480 Mass Spectrometer (ThermoScientific) for the Medical University of South Carolina Mass Spectrometry Facility and Proteomics Center to support our NIH funded investigators’ efforts to discover mechanisms of protein regulation involved in cardiovascular disease, cancer, immunotherapy, digestive disease, diabetes, musculoskeletal diseases, addiction, and neurological diseases. Our users are relying on ThermoScientific Orbitrap LC-MS/MS ETD systems purchased in 2012 and 2018 (S10 OD010731 and S10 OD025126, PI: Lauren Ball) to characterize the impact of drugs/hormones, genetic alterations, and disease on changes in protein expression, protein interactions, and post-translational modifications. With the recent funding successes of new users and an increased number of NIH awards to our major user group, we are experiencing a greater demand for instrument time. To address the increased need for quantitative proteomic experiments and provide highly-sensitive, targeted-proteomic capabilities for the analysis of post-translationally modified proteins from limited amounts of sample, we are requesting the state-of-the-art Quadrupole Orbitrap Hybrid Exploris 480 MS. The requested instrumentation is to be housed in the Mass Spectrometry Facility, a University Research Resource Facility, to provide quantitative proteomic capabilities to investigators at the Medical University of South Carolina and other academic research institutions in South Carolina.project_title:
Quadrupole Orbitrap Hybrid Mass Spectrometer for Proteomicscontact_pi_name:
BALL, LAUREN ELIZABETHtotal_cost:
$772,651.00total_cost:
$1.00is_active:
Nobudget_end:
08/02/2019date_added:
08/04/2018agency_code:
NIHfiscal_year:
2018project_num:
1S10OD025126-01award_amount:
$990,760.00budget_start:
08/03/2018org_name:
MEDICAL UNIVERSITY OF SOUTH CAROLINAorg_state:
SCorg_country:
UNITED STATESorg_zipcode:
294074636primary_duns:
183710748abstract_text:
This proposal is requesting funds to acquire an Orbitrap Fusion Lumos ETD Mass Spectrometer for the Medical University of South Carolina to support our NIH funded investigators' efforts to discover mechanisms of protein regulation involved in cardiovascular disease, cancer, diabetes, osteoporosis, addiction, and neurological diseases. Currently, investigators are relying on one Orbitrap Elite instrument to characterize the impact of drugs/hormones, genetic alterations, and disease on changes in protein expression, protein interactions, and post-translational modifications. This instrument, purchased in 2012 specifically for the ability to couple multiple fragmentation capabilities with high resolution mass measurements, has been used by over 80 investigators and operates with a growing backlog. To provide our investigators with timely access to instrumentation, meet the growing demand for quantitative experiments, enable additional fragmentation capabilities for the detection of post-translational modifications, while addressing the diverse needs of the user base an Orbitrap Fusion Lumos ETD is requested. This tribrid instrument with ion trap, orbitrap, and quadrupole mass analyzers is faster and exhibits improved selection of precursor ions within a narrow mass range thereby increasing the sensitivity, selectivity, and reproducibility of measurements. For the analysis of post-translationally modified proteins, the instrument has added fragmentation capabilities (hybrid EThcD and high capacity ETD) for more confident site assignment of fragile modifications such as O-GlcNAc modification, detection of redox-sensitive modifications, and characterization of glycopeptides. The requested instrumentation is to be housed in the Mass Spectrometry Facility, a University Research Resource Facility, to provide LC-MS/MS based proteomic capabilities to investigators at the Medical University of South Carolina and the surrounding academic research institutions in South Carolina.project_title:
Orbitrap Fusion Lumos ETD Mass Spectrometercontact_pi_name:
BALL, LAUREN ELIZABETHtotal_cost:
$600,000.00total_cost:
$390,760.00Services are offerred outside of
Consulting is offerred outside of Medical University of South Carolina
Last Updated: 04/29/2026